Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats (Q43199663)

15 November 2017

title

Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats (English)

1 reference

15 November 2017

1 reference

Eun Hui Bae

1

1 reference

15 November 2017

In Jin Kim

series ordinal

2

1 reference

15 November 2017

Seong Kwon Ma

series ordinal

3

1 reference

15 November 2017

Soo Wan Kim

series ordinal

4

1 reference

15 November 2017

publication date

8 January 2010

1 reference

15 November 2017

published in

Hypertension Research

1 reference

15 November 2017

volume

33

1 reference

15 November 2017

issue

3

1 reference

15 November 2017

page(s)

255-262

1 reference

Thiazolidinediones: a new class of antidiabetic drugs

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Effects of pioglitazone on metabolic control and blood pressure: a randomised study in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Aldosterone-induced inflammation in the rat heart : role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Expression of peroxisome proliferator-activated receptor isoform proteins in the rat kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Calcium citrate ameliorates the progression of chronic renal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Increased expression and apical targeting of renal ENaC subunits in puromycin aminonucleoside-induced nephrotic syndrome in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Role of endothelin-1 in hypertension and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Induction of PPAR gamma mRNA and protein expression by rosiglitazone in chronic cyclosporine nephropathy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Agonist of peroxisome proliferator-activated receptor-gamma, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Glomerular osteopontin expression and macrophage infiltration in glomerulosclerosis of DOCA-salt rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Peroxisome proliferator-activated receptors and cardiovascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Effects of mitogen-activated protein kinase pathway and co-activator CREP-binding protein on peroxisome proliferator-activated receptor-gamma-mediated transcription suppression of angiotensin II type 1 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

PPAR-gamma activation inhibits angiotensin II synthesis, apoptosis, and proliferation of mesangial cells from spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

inferred from DOI database lookup

7 January 2021

based on heuristic

Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

inferred from DOI database lookup

7 January 2021

based on heuristic

Regulation of renal sodium transporters during severe inflammation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.217

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/HR.2009.217

1 reference

Dimensions Publication ID

15 November 2017

1031741312

0 references

1 reference